Funder
Innovative Medicines Initiative
Université de Genève
FP7 Science in Society
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference58 articles.
1. Mouton JW, Ambrose PG, Canton R, Drusano GL, Harbarth S, MacGowan A, et al. Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat. 2011;14(2):107–17. https://doi.org/10.1016/j.drup.2011.02.005.
2. European Medicines Agency. Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antimicrobial medicinal products. London; 2016. www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500210982.pdf.
3. de Velde F, Mouton JW, de Winter BCM, van Gelder T, Koch BCP. Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives. Pharmacol Res. 2018;134:280–8. https://doi.org/10.1016/j.phrs.2018.07.005.
4. Mouton JW, Brown DF, Apfalter P, Canton R, Giske CG, Ivanova M, et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect. 2012;18(3):E37–45. https://doi.org/10.1111/j.1469-0691.2011.03752.x.
5. Racine-Poon A, Wakefield J. Statistical methods for population pharmacokinetic modelling. Stat Methods Med Res. 1998;7(1):63–84. https://doi.org/10.1177/096228029800700106.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献